Except for the expression of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)1, SS-31 treatment did not reduce the expression of inflammatory genes in the AA model, possibly because of the severity of induced kidney lesions as seen in the histological slides (Figure 1). This evidence concerns the gene NFKB1 and medical procedure.